Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5859 posts found.

horrible_monster_vaccination

Anti-vaxxers: Vaccines in the age of populism

November 6, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing anti vaccine, anti-vaccine, history, medicine, populism, vaccines

Mistrust of the establishment has fuelled anti-vaccine sentiment in recent years, and adherence has waned as a result. Louis Goss …
Feature
5204602349_c87b204860_z

Aurobindo pharma initiate recall of blood pressure drug Ibesartan

November 6, 2018 Manufacturing and Production, Research and Development Aurobindo Pharma, FDA, heart drug, ibesartan, recall

Indian pharma firm Aurobindo Pharma Ltd has initiated a voluntary recall of 22 batches of blood pressure drug Ibesartan, due …
News
display-dummy-757451_1920

76% of patients no longer experience PTSD a year after MDMA-assisted psychotherapy

November 6, 2018 Manufacturing and Production, Research and Development MDMA, PTSD, mental health, psychotherapy, research

Promising phase II results suggest that MDMA-assisted psychotherapy may be an “innovative, efficacious treatment for posttraumatic stress disorder,” according to …
News
6813384933_1fb31d73fb_z

HIV drug reduces viral load by 99% within 4 weeks

November 6, 2018 Manufacturing and Production, Research and Development

HIV-drug Gammora may eliminate 99% of the HIV virus within four weeks of treatment, according to the results of a …
News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

November 2, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, GSK, ITH Pharma, J&J, JJ, NICE, Sanofi, Trump, top 10

Deals dominated the headlines this week as both Sanofi and AstraZeneca made billion dollar agreements. Meanwhile, the FDA gave magic …
News

Galectin-3: The protein paving new treatment avenues

November 1, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Galectin-3, Galectins, breast cancer, diabetes, heart disease, pharma

Matthew Blakeley, LADI-III Beamline Scientist at Institut Laue-Langevin (ILL) and Derek Logan, Associate Professor in Structural Biology at Lund University, …
Feature

Half of kidney cancer patients initially misdiagnosed

October 30, 2018 Manufacturing and Production Cancer, Kidney cancer, NHS, UK, diagnosis

Half of kidney cancer patients are initially misdiagnosed, according to data from Kidney Cancer UK’s patient survey. Despite being the …
News
shutterstock_339308225

UK MPs call for greater action on clinical transparency and trial reporting

October 30, 2018 Manufacturing and Production, Research and Development UK, c linical transparency, clinical trials, pharma, transparency

The UK’s House of Commons Science and Technology Committee has argued in a new report that the failure of clinical …
News
gsk_china_8

GSK announces results of three year trial into long-lasting HIV injection

October 30, 2018 Manufacturing and Production GSK, HIV, drugs, injection, medication

GlaxoSmithKline have announced the results of a three year investigation into a long acting, injectable, two-drug HIV regimen at the …
News

NHS to receive additional £20.5 billion each year from 2018 Budget

October 30, 2018 Manufacturing and Production Budget, Conservatives, Labour, NHS, mental health, politics

The NHS will receive an additional £20.5 billion a year until 2023-24, according to the Budget released yesterday. The confirmation …
News
slimming-2728331_960_720

Effective preventative therapies for type 2 diabetes are underused, new research argues

October 30, 2018 Manufacturing and Production, Research and Development, Sales and Marketing diabetes, obesity, pharma, prediabetes, type 2 diabetes

New research has warned that interventions which can effectively delay or prevent the development of type 2 diabetes are not …
News
shutterstock_243110086

Not so crystal clear: The EU’s clinical reporting problem

October 29, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing EBM Datalabs, clinical trial transparency, clinical trials, feature, pharma, transparency

With shocking new findings revealing that around half of all clinical trial results in Europe go unreported, Matt Fellows explores …
Feature
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

October 26, 2018 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, GSK, HDA, J&J, JJ, brexit, clinical trials, pharmafile, resutls, stockpiling, top 10

Winter is coming! And with it an assortment of promising and not so promising results from big pharma. While J&J …
News
gsk_china_2_2_0_1

GSK opens £54m API plant in Montrose, Scotland

October 25, 2018 Manufacturing and Production API, GSK, Scotland, manufacturing, montrose

British multinational GlaxoSmithKline has opened an API manufacturing plant in Montrose Scotland for its Ellipta respiratory medicines. The new facility …
News
roche

Roche’s Alecensa topples Pfizer’s Xalkori in Asian patients with ALK+ advanced lung cancer

October 23, 2018 Manufacturing and Production, Research and Development Alecensa, Cancer, ESMO 2018, Roche, lung cancer, pharma

Following up on the reveal of data concerning its immunotherapy Tecentriq in combination with chemotherapy in the treatment of non-small …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026